Loading...
Header Logo
Keywords
Last Name
KP Region

Laurel A Habel PhD

TitleResearch Scientist III
InstitutionKaiser Permanente Northern California
DepartmentDivision of Research
ORCID ORCID Icon0000-0002-7230-587X Additional info
vCardDownload vCard
    Other Positions
    TitleAssociate Director, Cancer
    InstitutionKaiser Permanente Northern California
    DepartmentDivision of Research


    Collapse Research 
    Collapse research activities and funding
    R01CA081302     (HABEL, LAUREL A)May 6, 1999 - Feb 28, 2005
    NIH/NCI
    DCIS--MAMMOGRAPHIC FEATURES AND PROGNOSIS
    Role: Principal Investigator

    R03CA083135     (HABEL, LAUREL A)Jul 15, 1999 - Jun 30, 2002
    NIH/NCI
    MAMMOGRAPHIC DENSITY AND BREAST CANCER AFTER DCIS
    Role: Principal Investigator

    R01CA089552     (HABEL, LAUREL A)Jul 15, 2002 - Jun 30, 2007
    NIH/NCI
    Mammographic Density in a Multi-Ethnic Cohort
    Role: Principal Investigator

    R01CA098838     (HABEL, LAUREL A)Dec 1, 2002 - Jul 31, 2014
    NIH/NCI
    Pharmaceuticals and Cancer
    Role: Principal Investigator

    R01CA166827     (SIEH, WEIVA)Aug 1, 2012 - May 31, 2017
    NIH/NCI
    Genome-Wide Association Study of Mammographic Density
    Role: Co-Principal Investigator

    R01CA168893     (HABEL, LAUREL A)Sep 21, 2012 - Jun 30, 2016
    NIH/NCI
    Mammographic Density &Prognosis among Breast Cancer Intrinsic Subtypes
    Role: Principal Investigator

    R01CA201358     (WITTE, JOHN S)Aug 1, 2016 - Jul 31, 2020
    NIH/NCI
    Genome-wide Pleiotropy Scan across Multiple Cancers
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Banegas MP, Emerson MA, Adams AS, Achacoso NS, Chawla N, Alexeeff S, Habel LA. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer. J Cancer Surviv. 2018 Dec; 12(6):794-802. PMID: 30338462.
      View in: PubMed
    2. Check DK, Albers KB, Uppal KM, Suga JM, Adams AS, Habel LA, Quesenberry CP, Sakoda LC. Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members. Lung Cancer. 2018 Nov; 125:51-56. PMID: 30429038.
      View in: PubMed
    3. Su KA, Habel LA, Achacoso NS, Friedman GD, Asgari MM. Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma. Br J Dermatol. 2018 Nov; 179(5):1088-1094. PMID: 29723931.
      View in: PubMed
    4. Bradley MC, Ferrara A, Achacoso N, Ehrlich SF, Quesenberry CP, Habel LA. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus. Cancer Epidemiol Biomarkers Prev. 2018 May; 27(5):525-530. PMID: 29716927.
      View in: PubMed
    5. Krieger N, Nabavi S, Waterman PD, Achacoso NS, Acton L, Schnitt SJ, Habel LA. Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old? Cancer Causes Control. 2018 Mar; 29(3):305-314. PMID: 29427260.
      View in: PubMed
    6. Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, Mäenpää HO, Männistö S, Metter EJ, Milne RL, Nomura AMY, Oliver SE, Parsons JK, Peeters PH, Platz EA, Riboli E, Ricceri F, Rinaldi S, Rissanen H, Sawada N, Schaefer CA, Schenk JM, Stanczyk FZ, Stampfer M, Stattin P, Stenman UH, Tjønneland A, Trichopoulou A, Thompson IM, Tsugane S, Vatten L, Whittemore AS, Ziegler RG, Allen NE, Key TJ, Travis RC. Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men. PLoS One. 2017; 12(12):e0187741. PMID: 29281666.
      View in: PubMed
    7. Alford SH, Divine G, Chao C, Habel LA, Janakiraman N, Wang Y, Feigelson HS, Scholes D, Roblin D, Epstein MM, Engel L, Havstad S, Wells K, Yood MU, Fortuny J, Johnson CC. Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis. Cancer Causes Control. 2018 Jan; 29(1):143-156. PMID: 29192350.
      View in: PubMed
    8. Emerson MA, Banegas MP, Chawla N, Achacoso N, Alexeeff SE, Adams AS, Habel LA. Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives. Cancer Res. 2017 12 01; 77(23):6770-6776. PMID: 29187399.
      View in: PubMed
    9. Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA. Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat. 2018 02; 167(3):751-759. PMID: 29079937.
      View in: PubMed
    10. Alexeeff SE, Odo NU, Lipson JA, Achacoso N, Rothstein JH, Yaffe MJ, Liang RY, Acton L, McGuire V, Whittemore AS, Rubin DL, Sieh W, Habel LA. Age at Menarche and Late Adolescent Adiposity Associated with Mammographic Density on Processed Digital Mammograms in 24,840 Women. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1450-1458. PMID: 28698185.
      View in: PubMed
    11. Pottegård A, Hallas J, Olesen M, Svendsen MT, Habel LA, Friedman GD, Friis S. Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med. 2017 10; 282(4):322-331. PMID: 28480532.
      View in: PubMed
    12. Epstein MM, Divine G, Chao CR, Wells KE, Feigelson HS, Scholes D, Roblin D, Ulcickas Yood M, Engel LS, Taylor A, Fortuny J, Habel LA, Johnson CC. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 08 01; 141(3):480-487. PMID: 28425616.
      View in: PubMed
    13. Krigbaum NY, Rubin RA, Cirillo PM, Terry MB, Habel LA, Morris C, Cohn BA. Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies. J Dev Orig Health Dis. 2017 Jun; 8(3):331-336. PMID: 28260556.
      View in: PubMed
    14. Jackson EA, Ruppert K, Derby CA, Lian Y, Neal-Perry G, Habel LA, Tepper PG, Harlow SD, Solomon DH. Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN). J Am Heart Assoc. 2017 Feb 23; 6(3). PMID: 28232324.
      View in: PubMed
    15. Lieu TA, Ray GT, Prausnitz SR, Habel LA, Alexeeff S, Li Y, Ramsey SD, Phelps CE, Chawla N, C O'Neill S, Mandelblatt JS. Oncologist and organizational factors associated with variation in breast cancer multigene testing. Breast Cancer Res Treat. 2017 May; 163(1):167-176. PMID: 28224383.
      View in: PubMed
    16. Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR, Ghai NR, Aaronson D, Presti J, Nordström T, Wang Z, Berndt SI, Chanock SJ, Mosley JD, Klein RJ, Middha M, Lilja H, Melander O, Kvale MN, Kwok PY, Schaefer C, Risch N, Van Den Eeden SK, Witte JS. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun. 2017 01 31; 8:14248. PMID: 28139693.
      View in: PubMed
    17. Friedman GD, Achacoso N, Habel LA. Research Letter: Anticholinergic Drugs and the Gallbladder -A Neglected Effect? Perm J. 2017; 21. PMID: 28488984.
      View in: PubMed
    18. Chau SL, Alabaster A, Luikart K, Brenman LM, Habel LA. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening. J Prim Care Community Health. 2017 Apr; 8(2):55-62. PMID: 27799412.
      View in: PubMed
    19. Pottegård A, Schmidt SA, Olesen AB, Achacoso N, Van Den Eeden SK, Hallas J, Sørensen HT, Friis S, Habel LA. Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma. Br J Cancer. 2016 09 27; 115(7):895-900. PMID: 27529513.
      View in: PubMed
    20. Jones LW, Kwan ML, Weltzien E, Chandarlapaty S, Sternfeld B, Sweeney C, Bernard PS, Castillo A, Habel LA, Kroenke CH, Langholz BM, Queensberry CP, Dang C, Weigelt B, Kushi LH, Caan BJ. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22. PMID: 27488523; PMCID: PMC5026589 [Available on 09/15/17].
    21. Friedman GD, Achacoso N, Fireman B, Habel LA. Statins and Reduced Risk of Liver Cancer: Evidence for Confounding. J Natl Cancer Inst. 2016 10; 108(10). PMID: 27381455.
      View in: PubMed
    22. Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Quesenberry CP, Scott J, Sternfeld B, Yu A, Kushi LH, Caan BJ. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9. PMID: 27217451.
      View in: PubMed
    23. Habel LA, Lipson JA, Achacoso N, Rothstein JH, Yaffe MJ, Liang RY, Acton L, McGuire V, Whittemore AS, Rubin DL, Sieh W. Case-control study of mammographic density and breast cancer risk using processed digital mammograms. Breast Cancer Res. 2016 05 21; 18(1):53. PMID: 27209070; PMCID: PMC4875652.
    24. Ray GT, Mandelblatt J, Habel LA, Ramsey S, Kushi LH, Li Y, Lieu TA. Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60. PMID: 27266581.
      View in: PubMed
    25. Kwan ML, Shi JM, Habel LA, Song J, Chung JW, Avila CC, Schottinger JE, Cheetham TC, Fletcher SW, Haque R. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89. PMID: 27002508.
      View in: PubMed
    26. Pottegård A, Friis S, Christensen Rd, Habel LA, Gagne JJ, Hallas J. Time for integrating clinical, lifestyle and molecular data to predict drug responses - Authors' reply. EBioMedicine. 2016 05; 7:11. PMID: 27322447; PMCID: PMC4909323.
    27. Pottegård A, Friis S, Christensen Rd, Habel LA, Gagne JJ, Hallas J. Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study. EBioMedicine. 2016 May; 7:73-9. PMID: 27322460; PMCID: PMC4909325.
    28. Travis RC, Appleby PN, Martin RM, Holly JMP, Albanes D, Black A, Bueno-de-Mesquita HBA, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Hamdy FC, Helzlsouer KJ, Hercberg S, Hoover RN, Janssen JAMJL, Kaaks R, Kubo T, Le Marchand L, Metter EJ, Mikami K, Morris JK, Neal DE, Neuhouser ML, Ozasa K, Palli D, Platz EA, Pollak M, Price AJ, Roobol MJ, Schaefer C, Schenk JM, Severi G, Stampfer MJ, Stattin P, Tamakoshi A, Tangen CM, Touvier M, Wald NJ, Weiss NS, Ziegler RG, Key TJ, Allen NE. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res. 2016 04 15; 76(8):2288-2300. PMID: 26921328; PMCID: PMC4873385 [Available on 10/15/16].
    29. Hassett MJ, Jiang W, Habel LA, Nekhlyudov L, Achacoso N, Acton L, Schnitt SJ, Schrag D, Punglia RS. Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community. Breast Cancer Res Treat. 2016 Feb; 155(3):541-9. PMID: 26843057; PMCID: PMC4767622 [Available on 02/03/17].
    30. Ferrara A, Lewis JD, Habel LA. Pioglitazone Use and Risk of Bladder Cancer--Reply. JAMA. 2015 Dec 15; 314(23):2568-9. PMID: 26670978.
      View in: PubMed
    31. Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, Avila C, Kleinman K, Habel LA, Fletcher SW, Kwan ML. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016 Mar; 108(3). PMID: 26631176.
      View in: PubMed
    32. Krieger N, Habel LA, Waterman PD, Shabani M, Ellison-Loschmann L, Achacoso NS, Acton L, Schnitt SJ. Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009). NPJ Breast Cancer. 2015; 1. PMID: 26807440.
      View in: PubMed
    33. Arem H, Brinton LA, Moore SC, Gapstur SM, Habel LA, Johnson K, Kolonel LN, McCormack VA, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Weiderpass E, Cook MB, Matthews CE. Physical Activity and Risk of Male Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2015 Dec; 24(12):1898-901. PMID: 26404962.
      View in: PubMed
    34. Lewis JD, Habel LA, Quesenberry CP, Strom BL, Peng T, Hedderson MM, Ehrlich SF, Mamtani R, Bilker W, Vaughn DJ, Nessel L, Van Den Eeden SK, Ferrara A. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77. PMID: 26197187.
      View in: PubMed
    35. Collins LC, Achacoso N, Haque R, Nekhlyudov L, Quesenberry CP, Schnitt SJ, Habel LA, Fletcher SW. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S502-8. PMID: 26059650.
      View in: PubMed
    36. Hoffmann TJ, Van Den Eeden SK, Sakoda LC, Jorgenson E, Habel LA, Graff RE, Passarelli MN, Cario CL, Emami NC, Chao CR, Ghai NR, Shan J, Ranatunga DK, Quesenberry CP, Aaronson D, Presti J, Wang Z, Berndt SI, Chanock SJ, McDonnell SK, French AJ, Schaid DJ, Thibodeau SN, Li Q, Freedman ML, Penney KL, Mucci LA, Haiman CA, Henderson BE, Seminara D, Kvale MN, Kwok PY, Schaefer C, Risch N, Witte JS. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015 Aug; 5(8):878-91. PMID: 26034056; PMCID: PMC4527942.
    37. Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, Caron P, Turcotte V, Habel LA, Isaacs CJ, Riboli E, Weiderpass E, Cook MB. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol. 2015 Jun 20; 33(18):2041-50. PMID: 25964249; PMCID: PMC4461805.
    38. Friedman GD, Achacoso N, Habel LA. Confounding by alcohol use: benzodiazepines and risk of liver cancer. Br J Clin Pharmacol. 2015 May; 79(5):872-3. PMID: 25387597; PMCID: PMC4415724.
    39. Kwan ML, Bernard PS, Kroenke CH, Factor RE, Habel LA, Weltzien EK, Castillo A, Gunderson EP, Maxfield KS, Stijleman IJ, Langholz BM, Quesenberry CP, Kushi LH, Sweeney C, Caan BJ. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7). PMID: 25921910; PMCID: PMC4554253.
    40. Kwan ML, Kroenke CH, Sweeney C, Bernard PS, Weltzien EK, Castillo A, Factor RE, Maxfield KS, Stijleman IJ, Kushi LH, Quesenberry CP, Habel LA, Caan BJ. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278. PMID: 25884832; PMCID: PMC4403771.
    41. Haque R, Shi J, Schottinger JE, Ahmed SA, Chung J, Avila C, Lee VS, Cheetham TC, Habel LA, Fletcher SW, Kwan ML. A hybrid approach to identify subsequent breast cancer using pathology and automated health information data. Med Care. 2015 Apr; 53(4):380-5. PMID: 25769058.
      View in: PubMed
    42. Keegan TH, Kurian AW, Gali K, Tao L, Lichtensztajn DY, Hershman DL, Habel LA, Caan BJ, Gomez SL. Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. Am J Public Health. 2015 May; 105(5):938-46. PMID: 25790426.
      View in: PubMed
    43. Sakoda LC, Ferrara A, Achacoso NS, Peng T, Ehrlich SF, Quesenberry CP, Habel LA. Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9. PMID: 25644512; PMCID: PMC4316372.
    44. Hoffmann TJ, Sakoda LC, Shen L, Jorgenson E, Habel LA, Liu J, Kvale MN, Asgari MM, Banda Y, Corley D, Kushi LH, Quesenberry CP, Schaefer C, Van Den Eeden SK, Risch N, Witte JS. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930. PMID: 25629170; PMCID: PMC4309593.
    45. Makboon K, Gold EB, Harvey DJ, Butler LM, Habel LA. Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort. Cancer Causes Control. 2015 Mar; 26(3):431-42. PMID: 25604866; PMCID: PMC4465075.
    46. Feigelson HS, Carroll NM, Weinmann S, Haque R, Yu CL, Butler MG, Waitzfelder B, Wrenn MG, Capra A, McGlynn EA, Habel LA. Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans. Springerplus. 2015; 4:24. PMID: 25625043; PMCID: PMC4300310.
    47. Cook MB, Guénel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den Eeden SK, Ewertz M, Falk RT, Gaudet MM, Gkiokas G, Habel LA, Hsing AW, Johnson K, Kolonel LN, La Vecchia C, Lynge E, Lubin JH, McCormack VA, Negri E, Olsson H, Parisi D, Petridou ET, Riboli E, Sesso HD, Swerdlow A, Thomas DB, Willett WC, Brinton LA. Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):520-31. PMID: 25515550.
      View in: PubMed
    48. Fehrenbacher L, Capra A, Habel L. Reply to L. Cabel et al. J Clin Oncol. 2015 Jan 20; 33(3):292-3. PMID: 25512452.
      View in: PubMed
    49. Fehrenbacher L, Capra AM, Quesenberry CP, Fulton R, Shiraz P, Habel LA. Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system. J Clin Oncol. 2014 Jul 10; 32(20):2151-8. PMID: 24888815.
      View in: PubMed
    50. Greenberg CC, Habel LA, Hughes ME, Nekhlyudov L, Achacoso N, Acton L, Schrag D, Jiang W, Edge S, Weeks JC, Punglia RS. Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2014 Nov; 21(12):3766-73. PMID: 24859938; PMCID: PMC4539255.
    51. Tran TN, Ray GT, Horberg MA, Yawn BP, Castillo AL, Saddier P, Habel LA. Complications of herpes zoster in cancer patients. Scand J Infect Dis. 2014 Jul; 46(7):528-32. PMID: 24796470.
      View in: PubMed
    52. Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May; 52(5):e30-8. PMID: 22643199; PMCID: PMC3482414.
    53. Lewis JD, Habel L, Quesenberry C, Mamtani R, Peng T, Bilker WB, Hedderson M, Nessel L, Vaughn DJ, Strom BL, Ferrara A. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45. PMID: 24764283.
      View in: PubMed
    54. Kroenke CH, Sweeney C, Kwan ML, Quesenberry CP, Weltzien EK, Habel LA, Castillo A, Bernard PS, Factor RE, Kushi LH, Caan BJ. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99. PMID: 24604094; PMCID: PMC4035036.
    55. Sweeney C, Bernard PS, Factor RE, Kwan ML, Habel LA, Quesenberry CP, Shakespear K, Weltzien EK, Stijleman IJ, Davis CA, Ebbert MT, Castillo A, Kushi LH, Caan BJ. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24. PMID: 24521995; PMCID: PMC4011983.
    56. Caan BJ, Sweeney C, Habel LA, Kwan ML, Kroenke CH, Weltzien EK, Quesenberry CP, Castillo A, Factor RE, Kushi LH, Bernard PS. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34. PMID: 24521998; PMCID: PMC4105204.
    57. Chan JK, Urban R, Capra AM, Jacoby V, Osann K, Whittemore A, Habel LA. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy. Obstet Gynecol. 2014 Jan; 123(1):65-72. PMID: 24463665; PMCID: PMC4624417.
    58. Friedman GD, Schwalbe J, Achacoso N, Meng MV, Kroenke CH, Habel LA. Antidepressants and testicular cancer. Cancer Causes Control. 2014 Feb; 25(2):251-8. PMID: 24276357; PMCID: PMC3922298.
    59. Habel LA, Danforth KN, Quesenberry CP, Capra A, Van Den Eeden SK, Weiss NS, Ferrara A. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60. PMID: 24170756; PMCID: PMC3836110.
    60. Collins LC, Achacoso N, Haque R, Nekhlyudov L, Fletcher SW, Quesenberry CP, Schnitt SJ, Habel LA. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat. 2013 Jun; 139(2):453-60. PMID: 23624751; PMCID: PMC4104603.
    61. Habel LA, Sakoda LC, Achacoso N, Ma XJ, Erlander MG, Sgroi DC, Fehrenbacher L, Greenberg D, Quesenberry CP. HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. Breast Cancer Res. 2013 Mar 14; 15(2):R24. PMID: 23497539; PMCID: PMC3672697.
    62. Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado GD. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2013 Mar; 22(3):365-73. PMID: 23275187; PMCID: PMC3596451.
    63. Kurian AW, Lichtensztajn DY, Keegan TH, Leung RW, Shema SJ, Hershman DL, Kushi LH, Habel LA, Kolevska T, Caan BJ, Gomez SL. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60. PMID: 23139057.
      View in: PubMed
    64. Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL, Quesenberry CP, Li Y, Sadier P, Tran TN. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):82-90. PMID: 23118142.
      View in: PubMed
    65. Goddard KA, Bowles EJ, Feigelson HS, Habel LA, Alford SH, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm AK, Webster JA. Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care. 2012 Nov; 18(11):704-12. PMID: 23198713; PMCID: PMC4061608.
    66. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33. PMID: 23053660; PMCID: PMC3507472.
    67. Friedman GD, Asgari MM, Warton EM, Chan J, Habel LA. Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med. 2012 Sep 10; 172(16):1246-51. PMID: 22869299; PMCID: PMC3809130.
    68. Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305. PMID: 22949432; PMCID: PMC3433392.
    69. Livaudais JC, Li C, John EM, Terry MB, Daly M, Buys SS, Habel L, Thompson B, Yanez ND, Coronado GD. Racial and ethnic differences in adjuvant hormonal therapy use. J Womens Health (Larchmt). 2012 Sep; 21(9):950-8. PMID: 22731764; PMCID: PMC3430474.
    70. Nekhlyudov L, Habel LA, Achacoso N, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SW. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst. 2012 Apr 18; 104(8):614-21. PMID: 22491230; PMCID: PMC3328423.
    71. Delate T, Bowles EJ, Pardee R, Wellman RD, Habel LA, Yood MU, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):673-80. PMID: 22337532; PMCID: PMC3319397.
    72. Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, Pham PT, Mulvihill MS, Ziaei F, Zhang H, Su B, Zhi X, Quesenberry CP, Habel LA, Deng Q, Wang Z, Zhou J, Li H, Huang MC, Yeh CC, Segal MR, Ray MR, Jones KD, Raz DJ, Xu Z, Jahan TM, Berryman D, He B, Mann MJ, Jablons DM. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32. PMID: 22285053; PMCID: PMC3294002.
    73. Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA. 2011 Dec 28; 306(24):2673-83. PMID: 22161946; PMCID: PMC3350308.
    74. Irizarry MC, Webb DJ, Boudiaf N, Logie J, Habel LA, Udaltsova N, Friedman GD. Risk of cancer in patients exposed to gabapentin in two electronic medical record systems. Pharmacoepidemiol Drug Saf. 2012 Feb; 21(2):214-25. PMID: 22144034; PMCID: PMC3314779.
    75. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011 Nov 17; 365(20):1896-904. PMID: 22043968; PMCID: PMC4943074.
    76. Friedman GD, Schwalbe JS, Habel LA. Re: a case-control study of levothyroxine and the risk of colorectal cancer. J Natl Cancer Inst. 2011 Nov 02; 103(21):1637-9. PMID: 22010174; PMCID: PMC3206041.
    77. Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI, Neugut AI, Fehrenbacher L, Thompson B, Coronado GD. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(2):607-17. PMID: 21922245.
      View in: PubMed
    78. Kabat GC, Kim MY, Woods NF, Habel LA, Messina CR, Wactawski-Wende J, Stefanick ML, Chlebowski RT, Wassertheil-Smoller S, Rohan TE. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Cancer Causes Control. 2011 Oct; 22(10):1415-24. PMID: 21750889.
      View in: PubMed
    79. Kwan ML, Greenlee H, Lee VS, Castillo A, Gunderson EP, Habel LA, Kushi LH, Sweeney C, Tam EK, Caan BJ. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205. PMID: 21559824; PMCID: PMC3272363.
    80. Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011 Sep; 129(2):549-56. PMID: 21479924; PMCID: PMC3145014.
    81. Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL, Habel LA, Vuga M, Cauley JA. A method to estimate off-schedule observations in a longitudinal study. Ann Epidemiol. 2011 Apr; 21(4):297-303. PMID: 21376277; PMCID: PMC3073647.
    82. Ferrara A, Lewis JD, Quesenberry CP, Peng T, Strom BL, Van Den Eeden SK, Ehrlich SF, Habel LA. Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9. PMID: 21447664; PMCID: PMC3064052.
    83. Conroy SM, Butler LM, Harvey D, Gold EB, Sternfeld B, Greendale GA, Habel LA. Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation. Int J Cancer. 2011 Oct 01; 129(7):1699-707. PMID: 21105041; PMCID: PMC3610563.
    84. Friedman GD, Udaltsova N, Habel LA. Norepinephrine antagonists and cancer risk. Int J Cancer. 2011 Feb 01; 128(3):737-8; author reply 739. PMID: 20333678; PMCID: PMC2993828.
    85. Yang YX, Habel LA, Capra AM, Achacoso NS, Quesenberry CP, Ferrara A, Levin TR, Lewis JD. Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3027-36. PMID: 20937982; PMCID: PMC3005371.
    86. Habel LA, Capra AM, Achacoso NS, Janga A, Acton L, Puligandla B, Quesenberry CP. Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2488-95. PMID: 20929881.
      View in: PubMed
    87. Woditschka S, Habel LA, Udaltsova N, Friedman GD, Sieh W. Lipophilic statin use and risk of breast cancer subtypes. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2479-87. PMID: 20729289; PMCID: PMC2952055.
    88. Baehner FL, Achacoso N, Maddala T, Shak S, Quesenberry CP, Goldstein LC, Gown AM, Habel LA. Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol. 2010 Oct 01; 28(28):4300-6. PMID: 20697093.
      View in: PubMed
    89. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care. 2010 Jul; 33(7):1674-85. PMID: 20587728; PMCID: PMC2890380.
    90. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010 Jul-Aug; 60(4):207-21. PMID: 20554718.
      View in: PubMed
    91. Haque R, Achacoso NS, Fletcher SW, Nekhlyudov L, Collins LC, Schnitt SJ, Quesenberry CP, Habel LA. Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care. 2010 May; 16(5):351-60. PMID: 20469955; PMCID: PMC3850784.
    92. Conroy SM, Butler LM, Harvey D, Gold EB, Sternfeld B, Oestreicher N, Greendale GA, Habel LA. Physical activity and change in mammographic density: the Study of Women's Health Across the Nation. Am J Epidemiol. 2010 May 01; 171(9):960-8. PMID: 20354074; PMCID: PMC2877475.
    93. Butler LM, Gold EB, Conroy SM, Crandall CJ, Greendale GA, Oestreicher N, Quesenberry CP, Habel LA. Active, but not passive cigarette smoking was inversely associated with mammographic density. Cancer Causes Control. 2010 Feb; 21(2):301-11. PMID: 19915951; PMCID: PMC2810361.
    94. Collins LC, Achacoso N, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Puligandla B, Alshak NS, Goldstein LC, Gown AM, Schnitt SJ, Habel LA. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8. PMID: 19950406; PMCID: PMC2788310.
    95. Friedman GD, Udaltsova N, Chan J, Quesenberry CP, Habel LA. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control. 2009 Dec; 20(10):1821-35. PMID: 19582585.
      View in: PubMed
    96. Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85. PMID: 19922614; PMCID: PMC2815548.
    97. Friedman GD, Jiang SF, Udaltsova N, Quesenberry CP, Chan J, Habel LA. Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity. Int J Cancer. 2009 Nov 01; 125(9):2173-8. PMID: 19585498; PMCID: PMC2759691.
    98. Flick ED, Habel LA, Chan KA, Haque R, Quinn VP, Van Den Eeden SK, Sternfeld B, Orav EJ, Seeger JD, Quesenberry CP, Caan BJ. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs. 2009 Jul 30; 69(11):1445-57. PMID: 19634923.
      View in: PubMed
    99. Crandall CJ, Sehl ME, Crawford SL, Gold EB, Habel LA, Butler LM, Sowers MR, Greendale GA, Sinsheimer JS. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast Cancer Res. 2009; 11(4):R51. PMID: 19630952; PMCID: PMC2750112.
    100. Nekhlyudov L, Habel LA, Achacoso NS, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SW. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 Jul 01; 27(19):3211-6. PMID: 19433691; PMCID: PMC2716942.
    101. Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL, Habel LA, Sternfeld B, Cauley JA. Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation. Int J Cancer. 2009 Mar 01; 124(5):1169-77. PMID: 19065651; PMCID: PMC2683677.
    102. Ray GT, Croen LA, Habel LA. Mothers of children diagnosed with attention-deficit/hyperactivity disorder: health conditions and medical care utilization in periods before and after birth of the child. Med Care. 2009 Jan; 47(1):105-14. PMID: 19106738; PMCID: PMC2775426.
    103. Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, Quesenberry C, Buffler P. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8. PMID: 18978173; PMCID: PMC2671084.
    104. Corley DA, Kubo A, Levin TR, Habel L, Zhao W, Leighton P, Rumore G, Quesenberry C, Buffler P, Block G. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004. PMID: 18853987; PMCID: PMC2671068.
    105. Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, Quesenberry C, Buffler P, Parsonnet J. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008 Oct; 13(5):352-60. PMID: 19250510; PMCID: PMC2714194.
    106. Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP, Habel LA. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1. PMID: 18930061; PMCID: PMC2628409.
    107. Friedman GD, Jiang SF, Udaltsova N, Chan J, Quesenberry CP, Habel LA. Pharmaceuticals that cause mammary gland tumors in animals: findings in women. Breast Cancer Res Treat. 2009 Jul; 116(1):187-94. PMID: 18629631; PMCID: PMC2695837.
    108. Friedman GD, Flick ED, Udaltsova N, Chan J, Quesenberry CP, Habel LA. Erratum: Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jul; 17(7):751. PMID: 18613276.
      View in: PubMed
    109. Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore GJ, Quesenberry C, Buffler P. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102. PMID: 18470614; PMCID: PMC2670929.
    110. Caan B, Habel L, Quesenberry C, Kushi L, Herrinton L. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599. PMID: 18398101.
      View in: PubMed
    111. Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M, Wassertheil-Smoller S, Page DL. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008 Apr 16; 100(8):563-71. PMID: 18398105.
      View in: PubMed
    112. Oestreicher N, Capra A, Bromberger J, Butler LM, Crandall CJ, Gold EB, Greendale GA, Modugno F, Sternfeld B, Habel LA. Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc. 2008 Mar; 40(3):451-6. PMID: 18379206.
      View in: PubMed
    113. Darbinian JA, Ferrara AM, Van Den Eeden SK, Quesenberry CP, Fireman B, Habel LA. Glycemic status and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2008 Mar; 17(3):628-35. PMID: 18349280.
      View in: PubMed
    114. Friedman GD, Flick ED, Udaltsova N, Chan J, Quesenberry CP, Habel LA. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jan; 17(1):27-36. PMID: 17944002.
      View in: PubMed
    115. Butler LM, Gold EB, Greendale GA, Crandall CJ, Modugno F, Oestreicher N, Quesenberry CP, Habel LA. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). Breast Cancer Res Treat. 2008 Nov; 112(1):165-74. PMID: 18066689; PMCID: PMC2664291.
    116. Oestreicher N, Friedman GD, Jiang SF, Chan J, Quesenberry C, Habel LA. Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1268-72. PMID: 18041106.
      View in: PubMed
    117. Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP, Habel LA. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202. PMID: 17603822.
      View in: PubMed
    118. Flick ED, Habel LA, Chan KA, Van Den Eeden SK, Quinn VP, Haque R, Orav EJ, Seeger JD, Sadler MC, Quesenberry CP, Sternfeld B, Jacobsen SJ, Whitmer RA, Caan BJ. Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25. PMID: 17971519.
      View in: PubMed
    119. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Rumore G, Quesenberry C, Buffler P, Parsonnet J. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33. PMID: 17895354; PMCID: PMC2670583.
    120. Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J, Crandall CJ, Gold EB, Modugno F, Salane M, Quesenberry C, Sternfeld B. Mammographic density in a multiethnic cohort. Menopause. 2007 Sep-Oct; 14(5):891-9. PMID: 17414171.
      View in: PubMed
    121. Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Alshak NS, Puligandla B, Brodsky GL, Schnitt SJ, Habel LA. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol. 2007 Nov; 20(11):1149-55. PMID: 17767135.
      View in: PubMed
    122. Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9. PMID: 17674197.
      View in: PubMed
    123. Haque R, Quinn VP, Habel LA, Enger SM, Sternfeld B, Van Den Eeden SK, Sadler M, Chiu V, Caan B. Correlates of screening sigmoidoscopy use among men in a large nonprofit health plan. Cancer. 2007 Jul 15; 110(2):275-81. PMID: 17559138.
      View in: PubMed
    124. Crandall CJ, Zheng Y, Karlamangla A, Sternfeld B, Habel LA, Oestreicher N, Johnston J, Cauley JA, Greendale GA. The association between mammographic breast density and bone mineral density in the study of women's health across the nation. Ann Epidemiol. 2007 Aug; 17(8):575-83. PMID: 17532645.
      View in: PubMed
    125. Grady D, Vittinghoff E, Lin F, Hanes V, Ensrud K, Habel LA, Wallace R, Macer J, Cummings SR, Shepherd J. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause. 2007 May-Jun; 14(3 Pt 1):391-6. PMID: 17224859.
      View in: PubMed
    126. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Quesenberry C, Rumore GJ, Buffler PA. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311. PMID: 17631128.
      View in: PubMed
    127. Kwan ML, Habel LA, Slattery ML, Caan B. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20. PMID: 17404892.
      View in: PubMed
    128. Friedman GD, Oestreicher N, Chan J, Quesenberry CP, Udaltsova N, Habel LA. Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer Epidemiol Biomarkers Prev. 2006 Nov; 15(11):2102-6. PMID: 17119034.
      View in: PubMed
    129. Ray GT, Levine P, Croen LA, Bokhari FA, Hu TW, Habel LA. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity. Arch Pediatr Adolesc Med. 2006 Oct; 160(10):1063-9. PMID: 17018466.
      View in: PubMed
    130. Enger SM, Van den Eeden SK, Sternfeld B, Loo RK, Quesenberry CP, Rowell S, Sadler MC, Schaffer DM, Habel LA, Caan BJ. California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health. 2006 Jun 30; 6:172. PMID: 16813653; PMCID: PMC1569841.
    131. Habel LA, Shak S, Jacobs MK, Capra A, Alexander C, Pho M, Baker J, Walker M, Watson D, Hackett J, Blick NT, Greenberg D, Fehrenbacher L, Langholz B, Quesenberry CP. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006; 8(3):R25. PMID: 16737553; PMCID: PMC1557737.
    132. Corley DA, Levin TR, Habel LA, Buffler PA. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44. PMID: 16573773.
      View in: PubMed
    133. Caan BJ, Emond JA, Natarajan L, Castillo A, Gunderson EP, Habel L, Jones L, Newman VA, Rock CL, Slattery ML, Stefanick ML, Sternfeld B, Thomson CA, Pierce JP. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006 Sep; 99(1):47-57. PMID: 16541317.
      View in: PubMed
    134. Habel LA, Pressman A, Ettinger B, Sidney S, Suh-Burgmann B, Fehrenbacher L, Quesenberry CP. Use of raloxifene among women with a history of breast cancer. Breast Cancer Res Treat. 2006 Mar; 96(2):123-9. PMID: 16319985.
      View in: PubMed
    135. Habel LA, Schaefer CA, Levine P, Bhat AK, Elliott G. Treatment with stimulants among youths in a large California health plan. J Child Adolesc Psychopharmacol. 2005 Feb; 15(1):62-7. PMID: 15741787.
      View in: PubMed
    136. Habel LA, Dignam JJ, Land SR, Salane M, Capra AM, Julian TB. Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst. 2004 Oct 06; 96(19):1467-72. PMID: 15467036; PMCID: PMC2935469.
    137. Efird JT, Friedman GD, Sidney S, Klatsky A, Habel LA, Udaltsova NV, Van den Eeden S, Nelson LM. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004 May; 68(1):57-69. PMID: 15174522.
      View in: PubMed
    138. Efird JT, Friedman GD, Habel L, Tekawa IS, Nelson LM. Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol. 2002 Oct; 12(7):469-75. PMID: 12377424.
      View in: PubMed
    139. Habel LA, Zhao W, Stanford JL. Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control. 2002 Jun; 13(5):427-34. PMID: 12146847.
      View in: PubMed
    140. Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40. PMID: 11874995.
      View in: PubMed
    141. Shibata A, Parsonnet J, Longacre TA, Garcia MI, Puligandla B, Davis RE, Vogelman JH, Orentreich N, Habel LA. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis. 2002 Mar; 23(3):419-24. PMID: 11895856.
      View in: PubMed
    142. Shibata A, Longacre TA, Puligandla B, Parsonnet J, Habel LA. Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists. Cancer Epidemiol Biomarkers Prev. 2001 Jan; 10(1):75-8. PMID: 11205493.
      View in: PubMed
    143. Habel LA, Van Den Eeden SK, Friedman GD. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate. 2000 May 01; 43(2):136-43. PMID: 10754529.
      View in: PubMed
    144. Habel LA, Levin TR, Friedman GD. Cimetidine use and risk of breast, prostate, and other cancers. Pharmacoepidemiol Drug Saf. 2000 Mar; 9(2):149-55. PMID: 19025815.
      View in: PubMed
    145. Friedman GD, Habel LA. Barbiturates and lung cancer: a re-evaluation. Int J Epidemiol. 1999 Jun; 28(3):375-9. PMID: 10405836.
      View in: PubMed
    146. Habel LA, Bull SA, Friedman GD. Barbiturates, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 1998 Nov; 7(11):1049-50. PMID: 9829715.
      View in: PubMed
    147. Habel LA, Daling JR, Newcomb PA, Self SG, Porter PL, Stanford JL, Seidel K, Weiss NS. Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 1998 Aug; 7(8):689-96. PMID: 9718221.
      View in: PubMed
    148. Van Den Eeden SK, Habel LA, Sherman KJ, McKnight B, Stergachis A, Daling JR. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study. Sex Transm Dis. 1998 Jul; 25(6):278-84. PMID: 9662760.
      View in: PubMed
    149. Habel LA, Van Den Eeden SK, Sherman KJ, McKnight B, Stergachis A, Daling JR. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis. 1998 Jul; 25(6):285-92. PMID: 9662761.
      View in: PubMed
    150. Habel LA, Moe RE, Daling JR, Holte S, Rossing MA, Weiss NS. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg. 1997 Jan; 225(1):69-75. PMID: 8998122; PMCID: PMC1190608.
    151. Rossing MA, Stanford JL, Weiss NS, Habel LA. Oral contraceptive use and risk of breast cancer in middle-aged women. Am J Epidemiol. 1996 Jul 15; 144(2):161-4. PMID: 8678047.
      View in: PubMed
    152. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995 Jul 12; 274(2):137-42. PMID: 7596001.
      View in: PubMed
    153. Carter JJ, Wipf GC, Hagensee ME, McKnight B, Habel LA, Lee SK, Kuypers J, Kiviat N, Daling JR, Koutsky LA, et al. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J Infect Dis. 1995 Jul; 172(1):11-8. PMID: 7797899.
      View in: PubMed
    154. Habel LA, Stanford JL, Vaughan TL, Rossing MA, Voigt LF, Weiss NS, Daling JR. Occupation and breast cancer risk in middle-aged women. J Occup Environ Med. 1995 Mar; 37(3):349-56. PMID: 7796203.
      View in: PubMed
    155. Bairati I, Sherman KJ, McKnight B, Habel LA, Van den Eeden SK, Stergachis A, Daling JR. Diet and genital warts: a case-control study. Sex Transm Dis. 1994 May-Jun; 21(3):149-54. PMID: 8073343.
      View in: PubMed
    156. Kandall SR, Gaines J, Habel L, Davidson G, Jessop D. Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr. 1993 Jul; 123(1):120-6. PMID: 8320605.
      View in: PubMed
    157. Habel LA, Stanford JL. Hormone receptors and breast cancer. Epidemiol Rev. 1993; 15(1):209-19. PMID: 8405205.
      View in: PubMed
    158. Dietrich SL, Mosley JW, Lusher JM, Hilgartner MW, Operskalski EA, Habel L, Aledort LM, Gjerset GF, Koerper MA, Lewis BH, et al. Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group. Vox Sang. 1990; 59(3):129-35. PMID: 2124751.
      View in: PubMed
    159. Habel L, Kaye K, Lee J. Trends in reporting of maternal drug abuse and infant mortality among drug-exposed infants in New York City. Women Health. 1990; 16(2):41-58. PMID: 2368425.
      View in: PubMed
    Habel's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2019 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.